Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Eloro Resources Announces Restart of Definition Drilling Targeting Major Tin Discovery and High Grade Silver Zones at its Iska Iska Ag-Sn-Polymetallic Project, Potosi Department, Bolivia
-
Quebec's Digital Economy Could Employ a Quarter of Canada’s Tech Workers by 2030: New ICTC Report
-
Emerita Files NI 43-101 Technical Report for the IBW Project, Marking a 35% Increase in Total Indicated Resources and a 44% Increase in Total Inferred Resources
-
USA Rare Earth Announces $75 Million PIPE Investment
-
Shenandoah Telecommunications Company Reports First Quarter 2025 Results
-
Brookfield Infrastructure Reports Solid First Quarter 2025 Results
-
BioCryst to Present at Upcoming Investor Conferences
-
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
-
Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups
-
BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
-
MADD Canada’s Cpl. Cumming’s Watch Awards Honour Alberta Police Officers for their Efforts to Stop Impaired Driving
-
The Chefs’ Warehouse Reports First Quarter 2025 Financial Results
-
Giyani Announces Appointments of Gavin Horscroft and Sean Thijsse
-
Nusano Names Rachel Culbertson VP of Supply Chain
-
Veri Medtech (VRHI) Relaunches Veriheal.com
-
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
-
I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025
-
Larimar Therapeutics Reports First Quarter 2025 Financial Results
-
XORTX Provides Update on FDA Type B Meeting Request
-
Stingray to Release its Financial Results for the Fourth Quarter of Fiscal 2025
-
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
-
The Vita Coco Company Reports Strong First Quarter 2025 Financial Results
-
Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups
-
SunPower Reports Q1’25: $80.2M Revenue, $1.3M Profit¹
-
Davis Commodities Announces Strategic Joint Venture with Leading Malaysian Agri-Processor to Capitalize on Regional Policy Shifts and Secure Preferred Market Access
-
HydroGraph Announces Strategic Relationship and New Texas Production Facility
-
ScottsMiracle-Gro Reports Second Quarter Results; Gross Margin Improvement Drives EBITDA Growth
-
Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results
-
Sharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply Agreement
-
Chicago Atlantic BDC, Inc. Announces First Quarter 2025 Financial Results Conference Call
-
Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025
-
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
-
10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure
-
OTC Markets Group Welcomes Velo3D, Inc. to OTCQX
-
Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
-
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
-
Fitch updates Marex’s outlook to positive due to strong earnings and diversification of franchise
-
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
-
ECARX Announces First Quarter 2025 Unaudited Financial Results
-
NodThera’s Oral NLRP3 Inhibitor NT-0796 Enhances and Sustains Weight Loss in Combination with GLP-1
-
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
-
Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO
-
Gauzy Ltd. Sets Date for First Quarter 2025 Results
-
Notice on the convened Ordinary General Meeting of Shareholders of AB “KN Energies”
-
Martin Marietta Reports First-Quarter 2025 Results
-
YieldMax™ ETFs Announces Distributions on CONY (102.91%), FIAT (100.78%), CVNY (86.83%), ULTY (81.75%), YMAX (67.85%), and Others
-
Wabash Announces First Quarter 2025 Results
-
Utenos Trikotažas Group increased its sales by 66% in the first quarter and reduced losses by almost one million euros
-
Real Matters Reports Second Quarter Financial Results

